1. Home
  2. ARWR vs TDC Comparison

ARWR vs TDC Comparison

Compare ARWR & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • TDC
  • Stock Information
  • Founded
  • ARWR 2003
  • TDC 1979
  • Country
  • ARWR United States
  • TDC United States
  • Employees
  • ARWR N/A
  • TDC N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • TDC Computer Software: Prepackaged Software
  • Sector
  • ARWR Health Care
  • TDC Technology
  • Exchange
  • ARWR Nasdaq
  • TDC Nasdaq
  • Market Cap
  • ARWR 1.8B
  • TDC 2.2B
  • IPO Year
  • ARWR 1993
  • TDC 2007
  • Fundamental
  • Price
  • ARWR $15.32
  • TDC $21.35
  • Analyst Decision
  • ARWR Buy
  • TDC Hold
  • Analyst Count
  • ARWR 8
  • TDC 9
  • Target Price
  • ARWR $43.71
  • TDC $29.75
  • AVG Volume (30 Days)
  • ARWR 1.5M
  • TDC 939.7K
  • Earning Date
  • ARWR 08-07-2025
  • TDC 08-04-2025
  • Dividend Yield
  • ARWR N/A
  • TDC N/A
  • EPS Growth
  • ARWR N/A
  • TDC 241.18
  • EPS
  • ARWR N/A
  • TDC 1.41
  • Revenue
  • ARWR $545,209,000.00
  • TDC $1,703,000,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • TDC N/A
  • Revenue Next Year
  • ARWR N/A
  • TDC $0.36
  • P/E Ratio
  • ARWR N/A
  • TDC $15.13
  • Revenue Growth
  • ARWR 1436.97
  • TDC N/A
  • 52 Week Low
  • ARWR $9.57
  • TDC $18.43
  • 52 Week High
  • ARWR $30.41
  • TDC $35.60
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 46.47
  • TDC 41.13
  • Support Level
  • ARWR $15.19
  • TDC $21.35
  • Resistance Level
  • ARWR $16.06
  • TDC $22.49
  • Average True Range (ATR)
  • ARWR 0.68
  • TDC 0.51
  • MACD
  • ARWR -0.23
  • TDC -0.08
  • Stochastic Oscillator
  • ARWR 15.23
  • TDC 3.13

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About TDC Teradata Corporation

Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.

Share on Social Networks: